Pfizer (PFE) EV to CFO (2009 - 2026)

Pfizer (PFE) has reported EV to CFO for 18 consecutive years, with 152.15 the latest figure, recorded in Q2 2026.

• On a quarterly basis, EV to CFO rose 171.07% year-over-year to 152.15 in Q2 2026; TTM through Jun 2026 was 9.48, a 54.39% decrease from a year earlier, with the FY2025 full-year figure at 10.96, up 7.31% from the prior year.
• EV to CFO was 152.15 for Q2 2026 at Pfizer, up from 54.05 in the prior quarter.
• Over five years, EV to CFO peaked at 173.78 in Q2 2023 and troughed at 214.09 in Q2 2025.
• A 5-year average of 22.2 and a median of 30.26 in 2022 frame the typical range for EV to CFO.
• The widest YoY moves for EV to CFO: up 327.78% in 2023, down 522.35% in 2023.
• Over 5 years, EV to CFO stood at 31.87 in 2022, then decreased by 10.08% to 28.66 in 2023, then decreased by 10.09% to 25.76 in 2024, then decreased by 6.89% to 23.99 in 2025, then surged by 534.27% to 152.15 in 2026.
• The last three EV to CFO figures came in at 152.15 (Q2 2026), 54.05 (Q1 2026), and 23.99 (Q4 2025), per Business Quant data.